These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 27317687)

  • 1. Macrophage bone morphogenic protein receptor 2 depletion in idiopathic pulmonary fibrosis and Group III pulmonary hypertension.
    Chen NY; D Collum S; Luo F; Weng T; Le TT; M Hernandez A; Philip K; Molina JG; Garcia-Morales LJ; Cao Y; Ko TC; Amione-Guerra J; Al-Jabbari O; Bunge RR; Youker K; Bruckner BA; Hamid R; Davies J; Sinha N; Karmouty-Quintana H
    Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L238-54. PubMed ID: 27317687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular-Parenchymal Cross-Talk Promotes Lung Fibrosis through BMPR2 Signaling.
    Yanagihara T; Tsubouchi K; Zhou Q; Chong M; Otsubo K; Isshiki T; Schupp JC; Sato S; Scallan C; Upagupta C; Revill S; Ayoub A; Chong SG; Dvorkin-Gheva A; Kaminski N; Tikkanen J; Keshavjee S; Paré G; Guignabert C; Ask K; Kolb MRJ
    Am J Respir Crit Care Med; 2023 Jun; 207(11):1498-1514. PubMed ID: 36917778
    [No Abstract]   [Full Text] [Related]  

  • 3. Codependence of Bone Morphogenetic Protein Receptor 2 and Transforming Growth Factor-β in Elastic Fiber Assembly and Its Perturbation in Pulmonary Arterial Hypertension.
    Tojais NF; Cao A; Lai YJ; Wang L; Chen PI; Alcazar MAA; de Jesus Perez VA; Hopper RK; Rhodes CJ; Bill MA; Sakai LY; Rabinovitch M
    Arterioscler Thromb Vasc Biol; 2017 Aug; 37(8):1559-1569. PubMed ID: 28619995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of TIM-3 in Macrophages Aggravates Pathogenesis of Pulmonary Fibrosis in Mice.
    Wang Y; Kuai Q; Gao F; Wang Y; He M; Zhou H; Han G; Jiang X; Ren S; Yu Q
    Am J Respir Cell Mol Biol; 2019 Dec; 61(6):727-736. PubMed ID: 31162951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-6 modulates the expression of the bone morphogenic protein receptor type II through a novel STAT3-microRNA cluster 17/92 pathway.
    Brock M; Trenkmann M; Gay RE; Michel BA; Gay S; Fischler M; Ulrich S; Speich R; Huber LC
    Circ Res; 2009 May; 104(10):1184-91. PubMed ID: 19390056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BMPR2 mutation alters the lung macrophage endothelin-1 cascade in a mouse model and patients with heritable pulmonary artery hypertension.
    Talati M; West J; Blackwell TR; Loyd JE; Meyrick B
    Am J Physiol Lung Cell Mol Physiol; 2010 Sep; 299(3):L363-73. PubMed ID: 20562228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammation, endothelial injury, and persistent pulmonary hypertension in heterozygous BMPR2-mutant mice.
    Song Y; Coleman L; Shi J; Beppu H; Sato K; Walsh K; Loscalzo J; Zhang YY
    Am J Physiol Heart Circ Physiol; 2008 Aug; 295(2):H677-90. PubMed ID: 18552156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deletion of ADORA2B from myeloid cells dampens lung fibrosis and pulmonary hypertension.
    Karmouty-Quintana H; Philip K; Acero LF; Chen NY; Weng T; Molina JG; Luo F; Davies J; Le NB; Bunge I; Volcik KA; Le TT; Johnston RA; Xia Y; Eltzschig HK; Blackburn MR
    FASEB J; 2015 Jan; 29(1):50-60. PubMed ID: 25318478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomewide RNA expression profiling in lung identifies distinct signatures in idiopathic pulmonary arterial hypertension and secondary pulmonary hypertension.
    Rajkumar R; Konishi K; Richards TJ; Ishizawar DC; Wiechert AC; Kaminski N; Ahmad F
    Am J Physiol Heart Circ Physiol; 2010 Apr; 298(4):H1235-48. PubMed ID: 20081107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes virus infection is associated with vascular remodeling and pulmonary hypertension in idiopathic pulmonary fibrosis.
    Calabrese F; Kipar A; Lunardi F; Balestro E; Perissinotto E; Rossi E; Nannini N; Marulli G; Stewart JP; Rea F
    PLoS One; 2013; 8(2):e55715. PubMed ID: 23468849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CCL5 deficiency rescues pulmonary vascular dysfunction, and reverses pulmonary hypertension via caveolin-1-dependent BMPR2 activation.
    Nie X; Tan J; Dai Y; Liu Y; Zou J; Sun J; Ye S; Shen C; Fan L; Chen J; Bian JS
    J Mol Cell Cardiol; 2018 Mar; 116():41-56. PubMed ID: 29374556
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophage Migration Inhibitory Factor (MIF) Inhibition in a Murine Model of Bleomycin-Induced Pulmonary Fibrosis.
    Günther S; Bordenave J; Hua-Huy T; Nicco C; Cumont A; Thuillet R; Tu L; Quatremarre T; Guilbert T; Jalce G; Batteux F; Humbert M; Savale L; Guignabert C; Dinh-Xuan AT
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30567353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of bone morphogenetic protein receptor 2 is associated with abnormal DNA repair in pulmonary arterial hypertension.
    Li M; Vattulainen S; Aho J; Orcholski M; Rojas V; Yuan K; Helenius M; Taimen P; Myllykangas S; De Jesus Perez V; Koskenvuo JW; Alastalo TP
    Am J Respir Cell Mol Biol; 2014 Jun; 50(6):1118-28. PubMed ID: 24433082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMPR2 gene delivery reduces mutation-related PAH and counteracts TGF-β-mediated pulmonary cell signalling.
    Feng F; Harper RL; Reynolds PN
    Respirology; 2016 Apr; 21(3):526-32. PubMed ID: 26689975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The BMP Receptor 2 in Pulmonary Arterial Hypertension: When and Where the Animal Model Matches the Patient.
    Happé C; Kurakula K; Sun XQ; da Silva Goncalves Bos D; Rol N; Guignabert C; Tu L; Schalij I; Wiesmeijer KC; Tura-Ceide O; Vonk Noordegraaf A; de Man FS; Bogaard HJ; Goumans MJ
    Cells; 2020 Jun; 9(6):. PubMed ID: 32521690
    [No Abstract]   [Full Text] [Related]  

  • 17. Down-regulation of the inhibitor of growth family member 4 (ING4) in different forms of pulmonary fibrosis.
    Tzouvelekis A; Aidinis V; Harokopos V; Karameris A; Zacharis G; Mikroulis D; Konstantinou F; Steiropoulos P; Sotiriou I; Froudarakis M; Pneumatikos I; Tringidou R; Bouros D
    Respir Res; 2009 Feb; 10(1):14. PubMed ID: 19250543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition and role of let-7d in idiopathic pulmonary fibrosis.
    Pandit KV; Corcoran D; Yousef H; Yarlagadda M; Tzouvelekis A; Gibson KF; Konishi K; Yousem SA; Singh M; Handley D; Richards T; Selman M; Watkins SC; Pardo A; Ben-Yehudah A; Bouros D; Eickelberg O; Ray P; Benos PV; Kaminski N
    Am J Respir Crit Care Med; 2010 Jul; 182(2):220-9. PubMed ID: 20395557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron deposition and increased alveolar septal capillary density in nonfibrotic lung tissue are associated with pulmonary hypertension in idiopathic pulmonary fibrosis.
    Kim KH; Maldonado F; Ryu JH; Eiken PW; Hartman TE; Bartholmai BJ; Decker PA; Yi ES
    Respir Res; 2010 Apr; 11(1):37. PubMed ID: 20398288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.